StonvexLoading…
StonvexCore line items from MSI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q2 2026 2026-04-04 | Annual 2025 2025-12-31 | Q3 2025 2025-09-27 | Q2 2025 2025-06-28 |
|---|---|---|---|---|
Revenue | $2.71B | $11.68B | $8.30B | $5.29B |
Operating Income | $525.00M | $2.99B | $2.04B | $1.27B |
Net Income | $366.00M | $2.15B | $1.50B | $943.00M |
EPS (Diluted) | $2.18 | $12.75 | $8.89 | $5.57 |
Total Assets | $19.08B | $19.39B | $18.80B | $16.41B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $886.00M | $1.17B | $894.00M | $3.21B |
Free Cash Flow OCF − CapEx | $389.00M | $2.57B | $1.43B | $698.00M |
Shares Outstanding | 166.20M | 165.70M | 166.70M | 166.60M |